{"id":7600,"date":"2018-09-21T12:56:42","date_gmt":"2018-09-21T12:56:42","guid":{"rendered":"https:\/\/mda.brandncraft.com\/?p=7600"},"modified":"2026-01-27T14:01:03","modified_gmt":"2026-01-27T14:01:03","slug":"lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles","status":"publish","type":"post","link":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/","title":{"rendered":"L\u2019utilisation des biosimilaires pour le traitement du cancer : Les attitudes et perceptions actuelles"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>Depuis les ann\u00e9es 1990, les m\u00e9dicaments biologiques qui sont des produits \u00e0 base de prot\u00e9ines d\u00e9riv\u00e9s de cellules vivantes utilisant la biotechnologie, sont utilis\u00e9s comme option de traitement pour les patients vivant avec le cancer. Depuis 2009, des th\u00e9rapies biosimilaires (produits biologiques \u00e9quivalents sur le plan th\u00e9rapeutique) sont disponibles dans diff\u00e9rents domaines th\u00e9rapeutiques au Canada et ils sont sur le point de devenir disponibles pour une utilisation en oncologie. <\/p>\n","protected":false},"author":8,"featured_media":7613,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[62],"tags":[],"country-icon":[45,44],"class_list":["post-7600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-donnees-du-sondage-canada","country-icon-canada","country-icon-united-states"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>L\u2019utilisation des biosimilaires pour les traitements du cancer | Biosimilaires MD Analytics<\/title>\n<meta name=\"description\" content=\"MD Analytics a sond\u00e9 31 oncologues et h\u00e9matologues canadiens pour conna\u00eetre leurs point de vues concernant l&#039;utilisation des biosimilaires pour le traitement du cancer. Pour en savoir plus.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019utilisation des biosimilaires pour les traitements du cancer | Biosimilaires MD Analytics\" \/>\n<meta property=\"og:description\" content=\"MD Analytics a sond\u00e9 31 oncologues et h\u00e9matologues canadiens pour conna\u00eetre leurs point de vues concernant l&#039;utilisation des biosimilaires pour le traitement du cancer. Pour en savoir plus.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/\" \/>\n<meta property=\"og:site_name\" content=\"MD Analytics\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-21T12:56:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-27T14:01:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/09\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Daniel Turner, VP Client Services\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniel Turner, VP Client Services\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/\"},\"author\":{\"name\":\"Daniel Turner, VP Client Services\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#\\\/schema\\\/person\\\/218842d011574fcb0bdfc3f3a5bb5e7f\"},\"headline\":\"L\u2019utilisation des biosimilaires pour le traitement du cancer : Les attitudes et perceptions actuelles\",\"datePublished\":\"2018-09-21T12:56:42+00:00\",\"dateModified\":\"2026-01-27T14:01:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/\"},\"wordCount\":14,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png\",\"articleSection\":[\"R\u00e9sultats des sondages Canada\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/\",\"name\":\"L\u2019utilisation des biosimilaires pour les traitements du cancer | Biosimilaires MD Analytics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png\",\"datePublished\":\"2018-09-21T12:56:42+00:00\",\"dateModified\":\"2026-01-27T14:01:03+00:00\",\"description\":\"MD Analytics a sond\u00e9 31 oncologues et h\u00e9matologues canadiens pour conna\u00eetre leurs point de vues concernant l'utilisation des biosimilaires pour le traitement du cancer. Pour en savoir plus.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png\",\"contentUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png\",\"width\":900,\"height\":500,\"caption\":\"utilisation-des-biosimilaires-pour-traitement-cancer_FR-1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019utilisation des biosimilaires pour le traitement du cancer : Les attitudes et perceptions actuelles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/\",\"name\":\"MD Analytics\",\"description\":\"Health And Pharmaceutical Market Research | MD Analytics ULC\",\"publisher\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#organization\",\"name\":\"MD Analytics Inc.\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"MD Analytics Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#\\\/schema\\\/person\\\/218842d011574fcb0bdfc3f3a5bb5e7f\",\"name\":\"Daniel Turner, VP Client Services\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"contentUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"caption\":\"Daniel Turner, VP Client Services\"},\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/author\\\/dturner\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019utilisation des biosimilaires pour les traitements du cancer | Biosimilaires MD Analytics","description":"MD Analytics a sond\u00e9 31 oncologues et h\u00e9matologues canadiens pour conna\u00eetre leurs point de vues concernant l'utilisation des biosimilaires pour le traitement du cancer. Pour en savoir plus.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019utilisation des biosimilaires pour les traitements du cancer | Biosimilaires MD Analytics","og_description":"MD Analytics a sond\u00e9 31 oncologues et h\u00e9matologues canadiens pour conna\u00eetre leurs point de vues concernant l'utilisation des biosimilaires pour le traitement du cancer. Pour en savoir plus.","og_url":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/","og_site_name":"MD Analytics","article_published_time":"2018-09-21T12:56:42+00:00","article_modified_time":"2026-01-27T14:01:03+00:00","og_image":[{"width":900,"height":500,"url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/09\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png","type":"image\/png"}],"author":"Daniel Turner, VP Client Services","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Daniel Turner, VP Client Services","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/#article","isPartOf":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/"},"author":{"name":"Daniel Turner, VP Client Services","@id":"https:\/\/mda.brandncraft.com\/fr\/#\/schema\/person\/218842d011574fcb0bdfc3f3a5bb5e7f"},"headline":"L\u2019utilisation des biosimilaires pour le traitement du cancer : Les attitudes et perceptions actuelles","datePublished":"2018-09-21T12:56:42+00:00","dateModified":"2026-01-27T14:01:03+00:00","mainEntityOfPage":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/"},"wordCount":14,"commentCount":0,"publisher":{"@id":"https:\/\/mda.brandncraft.com\/fr\/#organization"},"image":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/#primaryimage"},"thumbnailUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/09\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png","articleSection":["R\u00e9sultats des sondages Canada"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/","url":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/","name":"L\u2019utilisation des biosimilaires pour les traitements du cancer | Biosimilaires MD Analytics","isPartOf":{"@id":"https:\/\/mda.brandncraft.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/#primaryimage"},"image":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/#primaryimage"},"thumbnailUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/09\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png","datePublished":"2018-09-21T12:56:42+00:00","dateModified":"2026-01-27T14:01:03+00:00","description":"MD Analytics a sond\u00e9 31 oncologues et h\u00e9matologues canadiens pour conna\u00eetre leurs point de vues concernant l'utilisation des biosimilaires pour le traitement du cancer. Pour en savoir plus.","breadcrumb":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/#primaryimage","url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/09\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png","contentUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/09\/utilisation-des-biosimilaires-pour-traitement-cancer_FR-1.png","width":900,"height":500,"caption":"utilisation-des-biosimilaires-pour-traitement-cancer_FR-1"},{"@type":"BreadcrumbList","@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-biosimilaires-pour-le-traitement-du-cancer-les-attitudes-et-perceptions-actuelles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mda.brandncraft.com\/fr\/"},{"@type":"ListItem","position":2,"name":"L\u2019utilisation des biosimilaires pour le traitement du cancer : Les attitudes et perceptions actuelles"}]},{"@type":"WebSite","@id":"https:\/\/mda.brandncraft.com\/fr\/#website","url":"https:\/\/mda.brandncraft.com\/fr\/","name":"MD Analytics","description":"Health And Pharmaceutical Market Research | MD Analytics ULC","publisher":{"@id":"https:\/\/mda.brandncraft.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mda.brandncraft.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/mda.brandncraft.com\/fr\/#organization","name":"MD Analytics Inc.","url":"https:\/\/mda.brandncraft.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mda.brandncraft.com\/fr\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"MD Analytics Inc."},"image":{"@id":"https:\/\/mda.brandncraft.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mda.brandncraft.com\/fr\/#\/schema\/person\/218842d011574fcb0bdfc3f3a5bb5e7f","name":"Daniel Turner, VP Client Services","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","contentUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","caption":"Daniel Turner, VP Client Services"},"url":"https:\/\/mda.brandncraft.com\/fr\/author\/dturner\/"}]}},"_links":{"self":[{"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/posts\/7600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/comments?post=7600"}],"version-history":[{"count":1,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/posts\/7600\/revisions"}],"predecessor-version":[{"id":7614,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/posts\/7600\/revisions\/7614"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/media\/7613"}],"wp:attachment":[{"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/media?parent=7600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/categories?post=7600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/tags?post=7600"},{"taxonomy":"country-icon","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/country-icon?post=7600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}